You are here: Industry Insights > women

News List

USPSTF Says Screen Women With Higher Risk for BRCA Mutations drugs
February 20, 2019
The U.S. Preventive Services Task Force (USPSTF) recommends screening for women at increased risk for carrying a BRCA1/2mutation as well as genetic counseling and testing as indicated for those screening positive.
Low-Income Women Lack Menstrual Hygiene Supplies drugs
January 17, 2019
Many low-income women cannot afford menstrual hygiene supplies, according to a study published online Jan. 8 in Obstetrics & Gynecology.....
Women With CVD Have Worse Self-Reported Outcomes drugs
January 09, 2019
Compared with men, women with atherosclerotic cardiovascular disease (ASCVD) are more likely to report poorer patient experience, lower health-related quality of life......
Type 2 Diabetes Risk Lower in Women With Active Migraine drugs
December 18, 2018
Women with active migraine have a lower risk for type 2 diabetes, according to a study published online Dec. 17 in JAMA Neurology......
Recalled Kotex Tampons Can Unravel Inside Body drugs
December 13, 2018
Certain Kotex tampons are being recalled by Kimberly-Clark because they can unravel and leave pieces inside women's bodies.There have been "a small number of reports of infections.....
Discovery to save more women in childbirth from postpartum hemorrhaging europeanpharmaceuticalreview
December 05, 2018
The development of a drug that could be used to save women from postpartum hemorrhaging, could save many thousands of women each year…
Women with pregnancy losses are at risk of cardiovascular disease pharmaceutical-technology
December 03, 2018
Research from the UK’s University of Cambridge and the University of North Carolina in the US has revealed women have an increased risk of cardiovascular disease from pregnancy losses and having five or more children......
2018's Fiercest Women in Life Sciences fiercepharma
November 06, 2018
Things are looking up for women—or so they seem. In the era of #MeToo, more and more women are speaking up about workplace harassment and discrimination, and the perpetrators are increasingly held accountable.
Women’s health firm KaNDy raises $32M for menopause study fiercebiotech
August 30, 2018
KaNDy Therapeutics now has the finances it needs to start a phase 2b trial of its nonhormonal therapy for menopausal symptoms, after raising £25 million (around $32M) in its series C.
Women's hormone drug prices have climbed for years, but controversy hasn't ensued. Why? fiercepharma
June 05, 2018
Another case hasn't garnered the same attention—and maybe that's because people just don't like to talk about vaginas.

Previous page 1 2 3 4 5 6 7 8 9 10 11 Next page